X-18642105-G-C
Variant summary
Our verdict is Pathogenic. The variant received 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000330.4(RS1):c.574C>G(p.Pro192Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P192R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000330.4 missense
Scores
Clinical Significance
Conservation
Publications
- CDKL5 disorderInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- precocious pubertyInheritance: XL Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| RS1 | NM_000330.4 | c.574C>G | p.Pro192Ala | missense_variant | Exon 6 of 6 | ENST00000379984.4 | NP_000321.1 | |
| RS1 | XM_047442337.1 | c.478C>G | p.Pro160Ala | missense_variant | Exon 4 of 4 | XP_047298293.1 | ||
| CDKL5 | NM_001037343.2 | c.2714-3902G>C | intron_variant | Intron 19 of 21 | NP_001032420.1 | |||
| CDKL5 | NM_003159.3 | c.2714-3902G>C | intron_variant | Intron 18 of 20 | NP_003150.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| RS1 | ENST00000379984.4 | c.574C>G | p.Pro192Ala | missense_variant | Exon 6 of 6 | 1 | NM_000330.4 | ENSP00000369320.3 | ||
| RS1 | ENST00000476595.1 | n.1065C>G | non_coding_transcript_exon_variant | Exon 5 of 5 | 1 | |||||
| CDKL5 | ENST00000379989.6 | c.2714-3902G>C | intron_variant | Intron 19 of 21 | 1 | ENSP00000369325.3 | ||||
| CDKL5 | ENST00000379996.7 | c.2714-3902G>C | intron_variant | Intron 18 of 20 | 1 | ENSP00000369332.3 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
not provided Pathogenic:1
In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Pro192 amino acid residue in RS1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9326935, 10533068, 28348004). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RS1 protein function. This variant has been observed in individual(s) with X-linked retinoschisis (PMID: 15937075). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with alanine at codon 192 of the RS1 protein (p.Pro192Ala). The proline residue is highly conserved and there is a small physicochemical difference between proline and alanine.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at